Skip to content

Role of Spectrophotometer in Early Prediction of Weaning Induced Cardiac Dysfunction

Role of Spectrophotometer in Early Prediction of Weaning Induced Cardiac Dysfunction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06674824
Enrollment
55
Registered
2024-11-05
Start date
2024-10-25
Completion date
2025-04-28
Last updated
2025-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weaning Failure

Keywords

Massimo

Brief summary

Weaning induced cardiac dysfunction is a common cause of weaning failure in critically ill patients. plethysmography variability index (PVI) is a non-invasive, real-time, and automated parameter for evalu¬ating fluid responsiveness. By proving the validity of (PVI) in predicting successful spontaneous breathing trial Massimo can be used an easy noninvasive method that help in deciding the right time for weaning.

Interventions

DEVICEmassimo

measure plethysmography variability index in patients on spontaneous trial planning for extubation and evaluate its sensitivity in relation to transthoracic echocardiographic velocity time integral in early detecting weaning induced pulmonary edema

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. Intubation and mechanical ventilation 2. Fulfilling criteria for extubation 3. Fraction inspired oxygen less than 50%

Exclusion criteria

* a. Hemodynamic instability b. b. tracheostomy

Design outcomes

Primary

MeasureTime frameDescription
accuracy of change PVI in detecting volume responsiveness1 houraccuracy of change PVI in detecting volume responsiveness through measuring limits of agreement , Bias and correlation between PVI and a standard method of measurement which left ventricular outflow tract velocity time integral

Secondary

MeasureTime frameDescription
Sensitivity of trend of changes in hemoglobin by Massimo to detect WIPO and1 hour
time in minutes between rise of hemoglobin and clinical diagnosis of WIPO1 hourminutes between rise of blood hemoglobin concentration measured by Massimo and clinical diagnosis of WIPO

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026